Delivery Order SPE2DB20D7061-SPE2DB25FSNJ2
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Pediarix/PedvaxHIB vaccine in 0.5mL vials, with a ceiling value of $2,161.34 and an ultimate completion date of November 12, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under...
- The Defense Logistics Agency awarded a $3,538.48 delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Pediarix HIB vaccine in 0.5ml vials. This competitively awarded, firm fixed-price contract is scheduled for ultimate completion on November 14, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting AmerisourceBergen's competitive positioning...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Pediarix HIB vaccine in 0.5 milliliter vials, with a ceiling value of $1,326.85 and an ultimate completion date of August 1, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The contract represents a child order under the company's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Pediarix HIB vaccine in 0.5ML vials, with a ceiling value of $1,938.38. This firm fixed price delivery order, which is due for completion by August 26, 2025, represents a competitively awarded non-set-aside contract supporting federal medical procurement needs. The order will be fulfilled at AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains...
- The Defense Logistics Agency awarded a delivery order valued at $1,115.70 to AmerisourceBergen Drug Corp for the supply of Pediarix HIB vaccine in 0.5ML vials. The contract, which was competitively awarded with no set-aside designation, carries a firm fixed price structure and an ultimate completion date of August 5, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,164.10 on August 12, 2025, for the supply of Pediarix HIB vaccine in 0.5mL vials. This contract utilizes firm fixed pricing with no set-aside designation, indicating it was competitively awarded. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The contract is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 2, 2025, for the supply of Pediarix/PedvaxHIB vaccine in 0.5 mL vials, with a ceiling value of $3,791.80 and an ultimate completion date of May 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a pediatric immunization product delivery...
- The Defense Logistics Agency awarded a $4,949.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Pediarix HIB vaccine in 0.5mL vials. Issued on August 11, 2025, with an ultimate completion date of August 12, 2025, this competitively awarded contract (no set-aside used) will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete purchase under AmerisourceBergen's larger pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $5,504.07 to AmerisourceBergen Drug Corp for the supply of Pediarix (Pedvaxhib) vaccine in 0.5mL vials. This contract was competitively awarded without set-aside provisions and is structured as a firm fixed-price delivery order, with a completion deadline of November 18, 2025. The vaccine will be delivered to the prime contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Pediarix HB vaccine in 0.5 mL vials with a ceiling value of $1,137.54. This is a firm fixed-price delivery order with an ultimate completion date of September 9, 2025, and represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle. The award was made on a competitive basis without any set-aside designation, and performance will be...
- SPE2DB20D7061Indefinite Delivery Contract
- SPE2DB20D7061-SPE2DB25FSNJ2Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Pediarix (Hib) vaccine in 0.5 mL vials, with a ceiling value of $1,324.88 and an ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026. The place of performance is located at AmerisourceBergen's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal vendor for military and veteran healthcare systems through its extensive portfolio of medical product deliveries. This vaccine delivery order exemplifies the company's role in supporting the Defense Health Agency and other government healthcare systems by supplying pharmaceutical products and medical supplies across multiple therapeutic domains. The contract carries no set-aside designation, demonstrating AmerisourceBergen's capability to compete successfully in open federal procurement for medical commodities essential to military medical readiness.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 5/30/25 |